Unique ID issued by UMIN | UMIN000051099 |
---|---|
Receipt number | R000054359 |
Scientific Title | Outcomes of patients receiving percutaneous cricothyrotomy: An observational study |
Date of disclosure of the study information | 2023/05/18 |
Last modified on | 2025/05/19 10:32:33 |
Outcomes of patients receiving percutaneous cricothyrotomy: An observational study
Outcomes of patients receiving percutaneous cricothyrotomy
Outcomes of patients receiving percutaneous cricothyrotomy: An observational study
Outcomes of patients receiving percutaneous cricothyrotomy
Japan |
Patients who received percutaneous cricothyrotomy
Anesthesiology | Intensive care medicine |
Others
NO
Investigation of outcomes of patients received cricothyrotomy by Selzinger method
Safety,Efficacy
Duration of device use
Observational
20 | years-old | <= |
Not applicable |
Male and Female
Patients undergoing cricothyrotomy in ICU/HCU
Patients whose procedures were performed by a physician other than an anesthesiologist
80
1st name | Masashi |
Middle name | |
Last name | Yokose |
Yokohama City University Hospital
Department of Anesthesiology and Critical Care Medicine
2360004
3-9, Fukuura, Kanazawa-ku, Yokohama, Kanagawa, Japan
+81457872800
yokose_p12@yahoo.co.jp
1st name | Masashi |
Middle name | |
Last name | Yokose |
Yokohama City University Hospital
Department of Anesthesiology and Critical Care Medicine
2360004
3-9, Fukuura, Kanazawa-ku, Yokohama, Kanagawa, Japan
+81457872800
yokose_p12@yahoo.co.jp
Yokohama City University
Yokohama City University
Self funding
The institutional ethics committee of Yokohama city university hospital
3-9, Fukuura, Kanazawa-ku, Yokohama, Kanagawa, Japan
+81457872800
rinri@yokohama-cu.ac.jp
NO
2023 | Year | 05 | Month | 18 | Day |
Unpublished
81
No longer recruiting
2022 | Year | 02 | Month | 03 | Day |
2022 | Year | 02 | Month | 02 | Day |
2023 | Year | 05 | Month | 18 | Day |
2026 | Year | 03 | Month | 31 | Day |
Collect the following information from the electronic medical record
1) age, sex, height, weight, weight change, history of smoking, past history, comorbidity, type of surgical procedure, SOFA score, APACHE II, duration of tracheal intubation
2) detail of the SBT, GCS, JCS, amount of intratracheal sputum
3) WBC, Hb, Plt, TP, serum albumin, total bill, AST, ALT, LDH, CRP. ALP, gamma GTP, BUN, creatinine, BS, PT-INR, APTT
4) Complications and side effects and their description
5) outcomes: duration of device placement, replacement after removed of the device, transition of tracheostomy, length of stay in ICU, length of hospital stay, ventilator free days, discharge/transfer/death, complications after discharge to general ward,
Analysis of primary outcome
Median and interquartile range for duration of device placement
Analysis of secondary outcome
Frequency (percentage) and median (interquartile range) for each parameter. The same evaluation is performed for the subgroups in the duration of device placement.
Exploring factors associated with length of device placement
Multiple regression analysis is performed on factors expected to be related, with the length of device placement as the independent variable. (age, sex, height, weight, SOFA, APACHE II, weight change, Presence of impaired consciousness, number of days the patient was intubated, RSBI, maximal inspiratory pressure, presence of one or more acute complications (reintubation, complications at insertion: bleeding, extratracheal insertion, vertical and subcutaneous emphysema, blood phlegm [lasting more than 1 day, airway obstruction])
2023 | Year | 05 | Month | 18 | Day |
2025 | Year | 05 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054359